BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 16227634)

  • 1. Aberrant expression of maspin in idiopathic inflammatory bowel disease is associated with disease activity and neoplastic transformation.
    Cao D; Wilentz RE; Abbruzzese JL; Ho L; Maitra A
    Int J Gastrointest Cancer; 2005; 36(1):39-46. PubMed ID: 16227634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphological, immunohistochemical and molecular features of inflammatory bowel disease associated colorectal carcinoma and associated mucosal lesions - Single institution experience.
    Kamarádová K; Vošmiková H; Rozkošová K; Ryška A; Tachecí I; Laco J
    Pathol Res Pract; 2019 Apr; 215(4):730-737. PubMed ID: 30679085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk for colorectal neoplasia in patients with inflammatory bowel disease and mucosa indefinite for dysplasia.
    Lai KK; Horvath B; Xie H; Wu X; Lewis BL; Pai RK; Plesec T; Patil DT; Gordon IO; Wang Y; Shen B; Goldblum JR; Liu X
    Inflamm Bowel Dis; 2015 Feb; 21(2):378-84. PubMed ID: 25569733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted next-generation sequencing supports serrated epithelial change as an early precursor to inflammatory bowel disease-associated colorectal neoplasia.
    Singhi AD; Waters KM; Makhoul EP; Parian A; Lazarev MG; Proksell SS; Dueker JM; Schwartz MB; Wald AI; Nikiforova MN; Montgomery EA
    Hum Pathol; 2021 Jun; 112():9-19. PubMed ID: 33727167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal low-grade tubuloglandular adenocarcinoma in inflammatory bowel disease.
    Levi GS; Harpaz N
    Am J Surg Pathol; 2006 Aug; 30(8):1022-9. PubMed ID: 16861975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotensin receptor 1 overexpression in inflammatory bowel diseases and colitis-associated neoplasia.
    Gui X; Liu S; Yan Y; Gao Z
    World J Gastroenterol; 2013 Jul; 19(28):4504-10. PubMed ID: 23901225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypermucinous, Goblet Cell-Deficient and Crypt Cell Dysplasias in Inflammatory Bowel Disease are Often Associated with Flat/Invisible Endoscopic Appearance and Advanced Neoplasia on Follow-Up.
    Choi WT; Salomao M; Zhao L; Alpert L; Setia N; Liao X; Drage MG; Westerhoff M; Cheng J; Lauwers GY; Ko HM
    J Crohns Colitis; 2022 Jan; 16(1):98-108. PubMed ID: 34232295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maspin expression was involved in colorectal adenoma-adenocarcinoma sequence and liver metastasis of tumors.
    Zheng H; Tsuneyama K; Cheng C; Takahashi H; Cui Z; Murai Y; Nomoto K; Takano Y
    Anticancer Res; 2007; 27(1A):259-65. PubMed ID: 17352241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemistry in the diagnosis of dysplasia in chronic inflammatory bowel disease colorectal polyps.
    B Brahim E; Mrabet A; Jouini R; Koubaa W; B Sidhom R; Elloumi H; Chadli A
    Arab J Gastroenterol; 2016 Sep; 17(3):121-126. PubMed ID: 27567189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel mouse model of inflammatory bowel disease links mammalian target of rapamycin-dependent hyperproliferation of colonic epithelium to inflammation-associated tumorigenesis.
    Deng L; Zhou JF; Sellers RS; Li JF; Nguyen AV; Wang Y; Orlofsky A; Liu Q; Hume DA; Pollard JW; Augenlicht L; Lin EY
    Am J Pathol; 2010 Feb; 176(2):952-67. PubMed ID: 20042677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis, and Crohn's disease.
    Dorer R; Odze RD
    Am J Surg Pathol; 2006 Jul; 30(7):871-7. PubMed ID: 16819330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prior colorectal neoplasia is associated with increased risk of ileoanal pouch neoplasia in patients with inflammatory bowel disease.
    Derikx LA; Kievit W; Drenth JP; de Jong DJ; Ponsioen CY; Oldenburg B; van der Meulen-de Jong AE; Dijkstra G; Grubben MJ; van Laarhoven CJ; Nagtegaal ID; Hoentjen F;
    Gastroenterology; 2014 Jan; 146(1):119-28.e1. PubMed ID: 24076060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-MET immunohistochemical expression in sporadic and inflammatory bowel disease associated lesions.
    Halliday G; Porter RJ; Black CJ; Arends MJ; Din S
    World J Gastroenterol; 2022 Apr; 28(13):1338-1346. PubMed ID: 35645542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical analysis of HNF4A and β-catenin expression to predict low-grade dysplasia in the colitis-neoplastic sequence.
    He Y; Chen L; Chen K; Sun Y
    Acta Biochim Biophys Sin (Shanghai); 2021 Jan; 53(1):94-101. PubMed ID: 33300557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stress response protein cirp links inflammation and tumorigenesis in colitis-associated cancer.
    Sakurai T; Kashida H; Watanabe T; Hagiwara S; Mizushima T; Iijima H; Nishida N; Higashitsuji H; Fujita J; Kudo M
    Cancer Res; 2014 Nov; 74(21):6119-28. PubMed ID: 25187386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic inflammatory bowel disease and cancer.
    Pohl C; Hombach A; Kruis W
    Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of JNK2 as carcinogenic factor in colitis-associated and sporadic colorectal carcinogenesis.
    Lessel W; Silver A; Jechorek D; Guenther T; Roehl FW; Kalinski T; Roessner A; Poehlmann-Nitsche A
    Carcinogenesis; 2017 May; 38(5):559-569. PubMed ID: 28383667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA flow cytometric and interobserver study of crypt cell atypia in inflammatory bowel disease.
    Wen KW; Umetsu SE; Goldblum JR; Gill RM; Kim GE; Joseph NM; Rabinovitch PS; Kakar S; Lauwers GY; Choi WT
    Histopathology; 2019 Oct; 75(4):578-588. PubMed ID: 31111543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of Activated Cdc42 Kinase1 in Colitis and Colorectal Neoplasms.
    Lv C; Zhao X; Gu H; Huang L; Zhou S; Zhi F
    Med Sci Monit; 2016 Dec; 22():4794-4802. PubMed ID: 27926694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXE1 and SYNE1 genes hypermethylation panel as promising biomarker in colitis-associated colorectal neoplasia.
    Papadia C; Louwagie J; Del Rio P; Grooteclaes M; Coruzzi A; Montana C; Novelli M; Bordi C; de' Angelis GL; Bassett P; Bigley J; Warren B; Atkin W; Forbes A
    Inflamm Bowel Dis; 2014 Feb; 20(2):271-7. PubMed ID: 24280874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.